Douglas Rex, MD; on behalf of the U.S. Multi-Society Task Force on Colorectal Cancer
Potential Conflicts of Interest: None disclosed.
Rex D., ; One-Year Risk for Advanced Colorectal Neoplasia. Ann Intern Med. 2013;158:638-639. doi: 10.7326/0003-4819-158-8-201304160-00018
Download citation file:
Published: Ann Intern Med. 2013;158(8):638-639.
TO THE EDITOR:
Martínez and colleagues (1) found that the U.K. colonoscopy postpolypectomy surveillance guidelines identified a high-risk group of patients who benefit from repeated colonoscopy at 1 year after baseline but for whom the U.S. Multi-Society Task Force on Colorectal Cancer (MSTF) guidelines recommend colonoscopy at 3 years (2). The authors acknowledged that advanced lesions detected at 1 year in the high-risk group were probably missed during the baseline examinations. Multiple adenomas are well-established as a predictor of missed lesions in tandem colonoscopy studies. The potential implications of this trial for the U.S. guidelines are substantial.
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only